Navigation Links
Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Date:2/29/2008

Total liabilities 1,530,554 1,834,313

SHAREHOLDERS' EQUITY 1,354,420 1,328,232

TOTAL LIABILITIES & SHAREHOLDERS'

EQUITY $2,884,974 $3,162,545

WARNER CHILCOTT LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(in thousands of U.S. dollars)

(Unaudited)

Quarter Ended Year Ended

Dec-31-07 Dec-31-06 Dec-31-07 Dec-31-06

CASH FLOWS FROM OPERATING

ACTIVITIES:

Net income / (loss) $19,687 $(8,520) $28,875 $(153,510)

Adjustments to reconcile net

income / (loss) to net cash

provided by operating

activities:

Depreciation 2,892 2,171 10,250 7,177

Amortization of intangible

assets 56,169 68,300 228,330 253,425

Amortization of debt finance

costs 3,280 11,135 13,813 30,154

Stock compensation expense 1,085 1,711 6,115 17,787

Accretion of preferred stock

in subsidiary - - - 26,190

Changes in assets and

liabilities:

Decrease / (increase) in

accounts receivable, prepaid

and other assets 12,742 12,780 1,852 (22,914)

(Increase) / decrease in

inventories (621) (6,955) 12,345 (34,978)

Increase in accounts payable,

accrued expenses & other

liabilities 17,107 1,888 32,430 7,933

(Decrease) / increase in

income taxes and other, net (6,507) (11,581) 5,540 (
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
6. Cepheid Reports Fourth Quarter and Full Year 2007 Results
7. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
8. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
9. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
10. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
11. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...y on creativity, sponsored by the Jerusalem-based ...eker, revealed that a majority of the Israeli scie...al methods that could "put them into a creati...s desired." , Jerusa...ey on creativity, sponsored by the Jerusalem-based...
(Date:7/24/2008)...-FirstCall/ -- NuVasive, Inc.,(Nasdaq: NUVA ), a ...cts for,minimally disruptive surgical treatments f...d the previously announced acquisition of the Oste...Inc. (Nasdaq: OSIR ) for $35,million in cash, plu...ot to,exceed $50 million in either cash or stock, ...
(Date:7/24/2008)...nary and critical care clinicians, and resear... DURHAM, N.C., July 24 /- bioMerieux...nferences of the American Thoracic Society and,Soc...sts, pulmonary and,critical care physicians, and r...thods and technologies are needed to quickly diagn...
(Date:7/24/2008)...e/ -- Instrumentation Laboratory,(IL) today announ...ervices,company, has awarded the Company with a fi...ts and services. Broadlane, based in Dallas, TX, c...ospitals, more than 2,600,sub-acute care facilitie...contract covers IL,s portfolio of critical care an...
Breaking Biology Technology:Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3NuVasive Completes Acquisition of Osteocel Biologics Business 2NuVasive Completes Acquisition of Osteocel Biologics Business 3NuVasive Completes Acquisition of Osteocel Biologics Business 4NuVasive Completes Acquisition of Osteocel Biologics Business 5U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis 2U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis 3Instrumentation Laboratory Announces Contract for Multi-Parameter Testing Products with Broadlane 2
...seful for dephosphorylation serine,threonine or...llen Simcox ,Stratagene Cloning Systems, Inc. ,... dualspecificity protein,phosphatase that has be...nity,tag, the calmodulinbinding peptide. The tag...s the enzyme to be removed subsequent to in vitro,...
...searchers , , Robert Buchner Peter L. Pin...,Stratagene Cloning Systems, Inc. , , Strata... the rat and human,NMDA receptor. In this articl...anscriptase-mediated polymerase chain reaction (RT... with Stratagenes rat cDNA, human cDNA and hNT,n...
...Kilty Phil Vickers ,Pfizer Central Research, Sa...PCR (DDPCR) is a widely used technique for,ident... types. Application of,DDPCR to allergic disease...mechanisms involved in allergic responses. In orde...roducible denaturing polyacrylamide gels are requi...
...llow isolation of gene products,with altered act...zelberger ,Institute for Technical Biochemistry,... Josef Altenbuchner ,Institute for Industrial Ge...any , Hartmut H. Meyer ,Institute for Organic ...ny , Mutants of an esterase (PFE) from Pseudomon...
Other Biology Technology:Highly Active and Removable AffinityTagged Lambda Phosphatase 2Highly Active and Removable AffinityTagged Lambda Phosphatase 3Highly Active and Removable AffinityTagged Lambda Phosphatase 4Gene-Specific Primers for NMDA Receptor Subunits 2Gene-Specific Primers for NMDA Receptor Subunits 3Gene-Specific Primers for NMDA Receptor Subunits 4Fractionating DNA Fragments Generated by Differential Display PCR 2Fractionating DNA Fragments Generated by Differential Display PCR 3Fractionating DNA Fragments Generated by Differential Display PCR 4Using XL1-Red Mutator Strain to Generate Esterase Variants 2Using XL1-Red Mutator Strain to Generate Esterase Variants 3Using XL1-Red Mutator Strain to Generate Esterase Variants 4Using XL1-Red Mutator Strain to Generate Esterase Variants 5
(Date:7/24/2008)... Harvard University and the University of Texas at...gly shaped by genes, efforts to prevent or tolerat...so suggests that the cost of errors in protein pro...es, rather than the loss of functional proteins. M..., like neurons, and cause neurodegenerative diseas...
(Date:7/24/2008)...oteins (NSP), a new family of genes discovered by ...earch and Molecular Medicine in Temple University,...lved in apoptosis or programmed cell death. , N... then a doctoral student at the University and now...sity and the Cardeza Foundation, and Antonio Giord...
(Date:7/24/2008)...uced carbon storage in western U.S. forests , A...entury has caused a widespread increase in fire-in...stems growing on trees within western U.S. forests...re thought to account for much of North America,s ...ound biomass, Fellows and Goulden compare Californ...
(Date:7/23/2008)...g in three estuaries on the Pacific coast of Calif...ined that biomass of these parasites exceeds that ...mes. , Their findings, which could have signific... in this week,s issue of the journal Nature . , ...s in a given habitat. It is expressed either as th...
Breaking Biology News(10 mins):Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3Novel structure proteins could play a role in apoptosis 2AGU journal highlights -- July 23, 2008 2AGU journal highlights -- July 23, 2008 3AGU journal highlights -- July 23, 2008 4AGU journal highlights -- July 23, 2008 5AGU journal highlights -- July 23, 2008 6AGU journal highlights -- July 23, 2008 7AGU journal highlights -- July 23, 2008 8Parasites outweigh predators in Pacific Coast estuaries 2Parasites outweigh predators in Pacific Coast estuaries 3The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease 6013 1The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease 6013 2New study shows American Cancer Society program helps employers 21954 1New study shows American Cancer Society program helps employers 21954 2New study shows American Cancer Society program helps employers 21954 3Fair trade 3649 2/ 1Project succeeding to relocate Caspian terns 3647 1Project succeeding to relocate Caspian terns 3647 2Project succeeding to relocate Caspian terns 3647 3Project succeeding to relocate Caspian terns 3647 4Project succeeding to relocate Caspian terns 3647 5Project succeeding to relocate Caspian terns 3647 6
...for Biological Studies have identified an enzyme t...muscle and restores normal muscle function in gene...dy, published online in Nature Medicine, is the fi...cade of events triggered by exercise-induced hormo...ay, a molecular switch turns on a set of muscle-sp...
...as the cause of the Neanderthal extinction in the ...niversity of Granada research group RNM 179 - Mine...phic environments, headed by professor Miguel Orte...z Espejo, Francisca Martínez Ruiz and David Galleg...ogy and Petrology of the University of Granada (Un...
...gy demanding organs of the human body. Its failur... each year. Similarly, the rainbow trout, native t...d food fish, requires dynamic and sustained cardia...ivity. , Previous studies of trout cardiac perfo...nder hypoxic (oxygen shortage) conditions, but gen...
...d older donors on a pump ?as opposed to the conven...n a cooler ?may lower hospital costs, improve init...re sharing of organs, according to new research by..."By placing kidneys on a portable pump, preservati...e for sharing organs across the country," said Rob...
Other Biology News:Salk scientists hammer out a pathway that promotes muscle cell survival in mice 2Climate change was the cause of Neanderthal extinction in the Iberian Peninsula 2Hearts of male and female rainbow trout are different 2Hearts of male and female rainbow trout are different 3Machine preservation may promote more organ sharing 2
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)
Detects caspase activation by flow cytometry.
Concentration: 1mg/ml. Antigen: Propidium Iodide
Apoptosis Detection Systems and Reagents
Biology Products: